IOL Implantation After KAMRA Inlay Removal

Inclusion Criteria: i. Subjects must sign and be given a copy of the informed consent form. ii. Subjects with BCDVA of 20/40 or worse, or significant visual symptoms/complaints as a result of cataract in the study eye. iii. Subjects must be \> 45 years of age at the time of screening. iv. Subjects must be willing and able to return for scheduled follow up examinations for 12 months after surgery. v. Subjects who underwent uneventful KAMRA inlay implantation and who currently still have the inlay in the eye. vi. Potential visual acuity following cataract removal and IOL implantation projected to be 0.8 or better (Snellen 20/25) as determined by diagnostic testing or investigator's medical judgment. Exclusion Criteria: i. Patients who had any type of intraocular surgery or refractive surgery (with the exception of KAMRA inlay implantation). ii. Requiring an intraocular lens outside the available power range of +15.5 to +27.5 diopters. iii. Pharmacologically dilated pupil size less than 6 mm or the presence of any pupil abnormalities (aniridia, non-reactive, fixed, or abnormally shaped pupils) or marked microphthalmos. iv. Preoperative corneal astigmatism \> 1.5 diopters (as determined by corneal topography or keratometry in either eye) or irregular corneal astigmatism. v. Corneal abnormalities such as stromal, epithelial or endothelial dystrophies, or diagnosed degenerative visual disorders (e.g., macular degeneration or other retinal disorders) that are predicted to cause visual acuity losses to a level of 0.8 or worse during the study. vi. Active or recurrent anterior segment pathology (chronic uveitis, iritis, iridocyclitis, rubeosis iridis, etc.). vii. Glaucoma suspect, uncontrolled ocular hypertension, or history of glaucomatous changes in the retina or visual field. viii. Subjects with uncontrolled systemic disease. ix. Subjects with previous retinal pathology in either eye.